Toshihiro Matsukawa

11PUBLICATIONS
46CO-AUTHORS
Predictive and prognostic markersHaematological tumoursHaematologyMedical mycologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 22, 2026
Drivers of temporal improvement in CAR T-cell therapy for large B-cell lymphoma: a Japanese nationwide registry analysis.

|Feb 10, 2026
Adverse karyotype amplifies risk in secondary acute myeloid leukemia (AML) and AML with myelodysplasia-related changes.

Toshihiro Matsukawa, Shota Yoshida, Masahiro Onozawa

|Mar 23, 2025
Early cardiotoxicity in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis after HLA-haploidentical hematopoietic stem cell transplantation.

Toshihiro Matsukawa, Junichi Sugita, Daigo Hashimoto

|Jul 19, 2023
Clinical implications of NUP98::NSD1 fusion at diagnosis in adult FLT3-ITD positive AML.

Toru Miyajima, Masahiro Onozawa, Shota Yoshida

|Aug 03, 2022
Mcm2 hypomorph leads to acute leukemia or hematopoietic stem cell failure, dependent on genetic context.

Toshihiro Matsukawa, Mianmian Yin, Timour Baslan

|Nov 17, 2021
Cytomegalovirus gastroenteritis in patients with acute graft-versus-host disease.

Yu Akahoshi, Shun-Ichi Kimura, Yuma Tada

Pageof 2

Frequent Collaborators

2 joint publications

Yoshiko Atsuta

2 joint publications

Takashi Ikeda

2 joint publications

Hideki Nakasone

2 joint publications

Peter D Aplan